Covid treatments

The U.S. government expects its supply of COVID-19 vaccines and antiviral treatments to run out over the next year and is preparing for them to be sold via the commercial market, the Department of Health and Human Services said on…

Researchers at the University of British Columbia have discovered what they are calling a “ weak spot” in the virus that causes COVID-19. A study published in the peer-reviewed scientific journal Nature Communications says the “key…

Great Britain has approved Pfizer‘s COVID-19 pill for patients over the age of 18 years who have mild to moderate infection and are at high risk of their illness worsening. The approval comes as the country scrambles to build…

Newly infected COVID-19 patients have two new treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear.The challenge is getting…

Merck is partnering with a pharmaceutical company in Ontario to make its oral COVID-19 antiviral pill in Canada. Merck, the maker of molnupiravir — which is still under Health Canada review — announced Monday it has reached an…

By Staff The Canadian Press Posted November 3, 2021 11:55 am …

AstraZeneca‘s antibody cocktail against COVID-19, which has proven to work as a preventative shot in the non-infected, was also shown to save lives and prevent severe disease when given as treatment within a week of first…

AstraZeneca has requested emergency use authorization from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system. In a statement on Tuesday, the…

Merck & Co. said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the…

By Staff The Associated Press Posted September 24, 2021 8:58 am   …